[
1. Sassa S. Modern diagnosis and management of the porphyrias. British Journal of Haematology, 2006; 135: 281–29210.1111/j.1365-2141.2006.06289.x16956347
]Search in Google Scholar
[
2. Mehta M., Rath G.P., Padhy U.P., Marda M., Mahajan C. and Dash H.D. Intensive care management of patients with acute intermittent porphyria: clinical report of four cases and review of literature. Indian J Crit Care Med. 2010; 14(2): 88–91.10.4103/0972-5229.68222293673820859493
]Search in Google Scholar
[
3. Handschin, C., Lin, J., Rhee, J., et al. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell, 2005;122: 505–515.10.1016/j.cell.2005.06.04016122419
]Search in Google Scholar
[
4. Innala E., Andersson C. Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden. Journal of Internal Medicine. 2011; 269(5):538-54510.1111/j.1365-2796.2010.02335.x21198994
]Search in Google Scholar
[
5. Stölzel U., Stauch T., Doss M.O. Porphyrias. Internist (Berl). 2010; 51(12): 1525-3310.1007/s00108-010-2751-x21104216
]Search in Google Scholar
[
6. Kovačević Z., Janićijević Petrovic M., Šarenac T., Mladenović V., Stojilković T. Acute intermittent Porphyria. PONS Med J. 2012; 9 (3):110-113.10.5937/pons1203110K
]Search in Google Scholar
[
7. Balwani M., Desnick R.J. The porphyrias: advances in diagnosis and treatment. Hematology 2012;120: 19-27
]Search in Google Scholar
[
8. Anderson K.E., Bloomer J.R., Bonkovsky H.L., et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med. 2005 Mar 15;142(6):439-50.10.7326/0003-4819-142-6-200503150-0001015767622
]Search in Google Scholar
[
9. Sardh E., Harper P., Andersson D.E., Floderus Y. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks. Eur J Intern Med. 2009 Mar;20(2):201-7.10.1016/j.ejim.2008.06.01219327613
]Search in Google Scholar
[
10. Harper P., Wahlin S. Treatment options in acute porphyria, porphyria cutanea tarda, and erythropoietic protoporphyria. Curr Treat Options Gastroenterol. 2007 Dec;10(6):444-55.10.1007/s11938-007-0044-918221605
]Search in Google Scholar
[
11. González-Arriaza H.L., Bostwick J.M. Acute Porphyrias: A Case Report and Review. Am J Psychiatry 2003; 160 (3):450-8.10.1176/appi.ajp.160.3.45012611823
]Search in Google Scholar
[
12. Puy H., Gouya L., Deybach J.C. Porphyrias. Lancet. 2010 Mar.13;375(9718): 924-37.10.1016/S0140-6736(09)61925-5
]Search in Google Scholar
[
13. Jose J, Saravu K, Shastry B A, Jimmy B. Drug use in porphyria: a therapeutic dilemma. Singapore Med J 2008; 49(10): e272-e275
]Search in Google Scholar
[
14. Andersson C., Lithner F. Hypertension and renal disease in patients with acute intermittent porphyria. Journal of Internal Medicine. 1994; 236(2):169-17510.1111/j.1365-2796.1994.tb01279.x
]Search in Google Scholar
[
15. Singh V., Sud K., Kohli H.S., Gupta K.L., Sakhuja V. Acute Intermittent Porphyria : An Unusual Cause of Malignant Hypertension. JAPI. 2003; (51): 225-226.
]Search in Google Scholar
[
16. Cinemre H, Korkmaz U, Alcelik A, Onder E, Gungor A. Safety of amlodipine use in patients with acute intermittent porphyria. Br J Clin Pharmacol 2007;64(2): 246–24710.1111/j.1365-2125.2007.02906.x
]Search in Google Scholar
[
17. Lambrecht R.W., Gildemeister O.S., Williams A., Pepe J.A., Tortorelli K.D., Bonkovsky H.L. Effects of selected antihypertensives and analgesics on hepatic porphyrin accumulation: implications for clinical porphyria. Biochem Pharmacol. 1999 Sep 1;58(5):887-9610.1016/S0006-2952(99)00154-9
]Search in Google Scholar
